Similar articles

• Regulation of the high Km cyclic nucleotide phosphodiesterase of adrenal medulla by the endogenous calcium-dependent-protein activator.

  Uzunov P, Gnegy ME, Revuelta A, Costa E. Uzunov P, et al. Biochem Biophys Res Commun. 1976 May 3;70(1):132-8. doi: 10.1016/0006-291x(76)91118-9. Biochem Biophys Res Commun. 1976. PMID: 179545 No abstract available.
• Characterization of cyclic nucleotide phosphodiesterases with multiple separation techniques.

  Van Inwegen RG, Pledger WJ, Strada SJ, Thompson WJ. Van Inwegen RG, et al. Arch Biochem Biophys. 1976 Aug;175(2):700-9. doi: 10.1016/0003-9861(76)90562-2. Arch Biochem Biophys. 1976. PMID: 183123 No abstract available.
• Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.

  Erneux C, Miot F. Erneux C, et al. Methods Enzymol. 1988;159:520-30. doi: 10.1016/0076-6879(88)59051-1. Methods Enzymol. 1988. PMID: 2842616 No abstract available.
• Multiplicity within cyclic nucleotide phosphodiesterases.

  Rybalkin SD, Beavo JA. Rybalkin SD, et al. Biochem Soc Trans. 1996 Nov;24(4):1005-9. doi: 10.1042/bst0241005. Biochem Soc Trans. 1996. PMID: 8968501 Review. No abstract available.
• Inhibitory and activators of cyclic nucleotide phosphodiesterase.

  Chasin M, Harris DN. Chasin M, et al. Adv Cyclic Nucleotide Res. 1976;7:225-64. Adv Cyclic Nucleotide Res. 1976. PMID: 188316 Review. No abstract available.